Table 3.

Infection follow-up of the obsessive–compulsive disorder group based on circulating immune complexes (BoDV-1 CIC)

H-group	Pat. No	Week 0*	Week 2	Week 4	Week 6	Week 12	Week 16	Levela
	1	187	80	54	70	246		Discontinuous
	2	280	323	137	80	74	154	Discontinuous
	3	445	136	299		376	29	Continuous
	4	179	172	201	70	43		Continuous
	5	230	19	76	48	66	169	Discontinuous
	6	1068	815	856	513	1060	468	Continuous
	7	678	662	515	624	309		Continuous
	8	399	165	362	258	434	381	Continuous
L-group	Pat. No	Week 0*	Week 2	Week 4	Week 6	Week 12	Week 16	Level
	9	66	132	145	145	54	47	Discontinuous
	10	52	223	209	181	94	35	Discontinuous
	11	154	302		155	368	218	Continuous
	12	58	140	160	193	170	214	Continuous
	13	137	326	193	215	286		Continuous
	14	96	142	200	205	128		Continuous
	15	164	111	355	61	81	117	Discontinuous
	16	162	132	67	89	151		Discontinuous

CICs = BoDV-1-specific circulating immune complexes in blood plasma, specific for BoDV-1 antigens p40/p24. The values of CICs are given as extinction at 405 nm × 1000, measured by enzyme immune assays (EIAs) at the starting dilution of 1:20 for each sample (see Methods). *The initial sampling was at week 0 and represented the basic virological results for H- and L-group patients in this study (see Table 2)

The cut off value of each test is ≥ 100. Results < 100 are regarded negative. H-group = patients with high CICs; L-group = patients with low CICs. ^aLevel: “Discontinuous” means changing activity levels of infection within 16 weeks (last sampling). “Continuous” means stable activity levels of infection at least for 4 weeks, up to 16 weeks (last sampling)